Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $7.5250 (4.81%) ($7.5250 - $7.5250) on Fri. Feb. 19, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.33% (three month average) | RSI | 72 | Latest Price | $7.5250(4.81%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR declines -0.7% a day on average for past five trading days. | Weekly Trend | CAPR advances 4.7% a week on average for past two weeks. | Market Behavior | Rotation from growth to value for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) IVE(84%) EMHY(78%) SPY(78%) FXI(69%) MCHI(68%) | Factors Impacting CAPR price | CAPR will decline at least -3.665% in a week (0% probabilities). OIH(-0%) UNG(6%) TBT(-12%) SIL(8%) VXX(-25%) | | | | | Relative Volatility | | | | Market Trend Strength | -3.665% (StdDev 7.33%) | Hourly BBV | 1 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $7.35(2.38%) | 10 Day Moving Average | $7.5(0.33%) | 20 Day Moving Average | $7.02(7.19%) | To recent high | -5.2% | To recent low | 43.3% | Market Cap | $148m | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |